These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of the intestinal tract in the elimination of uric acid. Sorensen LB Arthritis Rheum; 1965 Oct; 8(5):694-706. PubMed ID: 5859543 [No Abstract] [Full Text] [Related]
4. Evidence for a urate reabsorptive defect in patients with Wilson's disease. Wilson DM; Goldstein P Adv Exp Med Biol; 1974; 41():729-37. PubMed ID: 4832602 [No Abstract] [Full Text] [Related]
5. The effects of penicillamine therapy on uric acid metabolism in Wilson's disease. Sorensen LB; Kappas A Trans Assoc Am Physicians; 1966; 79():157-64. PubMed ID: 5954284 [No Abstract] [Full Text] [Related]
7. [Hepatolenticular degeneration. Present status of chemical pathology and treatment. I. Normal metabolism of copper and disorder of copper metabolism in hepatolenticular degeneration]. BOUDIN G; PEPIN B Presse Med (1893); 1962 Apr; 70():1027-30. PubMed ID: 13871780 [No Abstract] [Full Text] [Related]
8. [On the problem of amino acid metabolism in hepatolenticular degeneration]. PATRUNOVA VP Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():1146-52. PubMed ID: 13733346 [No Abstract] [Full Text] [Related]
9. COPPER metabolism in hepatolenticular degeneration. J Am Med Assoc; 1955 Jun; 158(5):402-3. PubMed ID: 14367097 [No Abstract] [Full Text] [Related]
10. Metabolism of copper in hepatolenticular degeneration. ZIMDAHL WT; HYMAN I; COOK ED Neurology; 1953 Aug; 3(8):569-76. PubMed ID: 13087576 [No Abstract] [Full Text] [Related]
12. [Recent data of metabolic alterations in hepatolenticular degeneration]. BARAC G Rev Med Liege; 1955 Aug; 10(16):504-7. PubMed ID: 13255463 [No Abstract] [Full Text] [Related]
13. Copper storage in hepatolenticular degeneration and allied diseases. CUMINGS JN Proc R Soc Med; 1954 Feb; 47(2):152-4. PubMed ID: 13134199 [No Abstract] [Full Text] [Related]
14. Wilson's disease in India. II. Biochemical and pathogenetic considerations in patients, parents, and siblings. Manghani DK; Dastur DK Neurology; 1968 Feb; 18(2):117-26. PubMed ID: 5688753 [No Abstract] [Full Text] [Related]
15. The mechanism of copper deposition in the liver in hepatolenticular degeneration (Wilson's disease). UZMAN LL; IBER FL; CHALMERS TC Am J Med Sci; 1956 May; 231(5):511-8. PubMed ID: 13313537 [No Abstract] [Full Text] [Related]
16. [Biochemical disorders and the treatment of hepatolenticular degeneration]. BOUDIN G; PEPIN B Bull Schweiz Akad Med Wiss; 1962 Jan; 17():389-95. PubMed ID: 13871778 [No Abstract] [Full Text] [Related]
17. Studies on hepatocerebral disease. III. Hepatolenticular degeneration in Japan, with studies on copper metabolism. OKINAKA S Neurology; 1961 Sep; 11():792-9. PubMed ID: 13730604 [No Abstract] [Full Text] [Related]
18. The intrahepatic distribution of copper in relation to the pathogenesis of hepatolenticular degeneration. UZMAN LL AMA Arch Pathol; 1957 Oct; 64(4):464-79. PubMed ID: 13457604 [No Abstract] [Full Text] [Related]
19. [The diagnostic and prognostic significance of enzyme findings in hepatolenticular degeneration]. TSCHABITSCHER H; SCHINKO H Wien Klin Wochenschr; 1961 May; 73():368-71. PubMed ID: 13778345 [No Abstract] [Full Text] [Related]